The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
6-Benzyl-4-(((2-hydroxy-6-methylquinolin-3-yl)methylene)amino)-3-thioxo-3,4-dihydro-1,2,4-triazin-5(2H)-one ID: ALA4857790
PubChem CID: 164609808
Max Phase: Preclinical
Molecular Formula: C21H17N5O2S
Molecular Weight: 403.47
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: Cc1ccc2nc(O)c(/C=N/n3c(=S)[nH]nc(Cc4ccccc4)c3=O)cc2c1
Standard InChI: InChI=1S/C21H17N5O2S/c1-13-7-8-17-15(9-13)11-16(19(27)23-17)12-22-26-20(28)18(24-25-21(26)29)10-14-5-3-2-4-6-14/h2-9,11-12H,10H2,1H3,(H,23,27)(H,25,29)/b22-12+
Standard InChI Key: RJLFFORRWAKCPP-WSDLNYQXSA-N
Molfile:
RDKit 2D
29 32 0 0 0 0 0 0 0 0999 V2000
36.0045 -4.2221 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.0034 -5.0417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.7114 -5.4506 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.7096 -3.8133 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.4183 -4.2185 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.4190 -5.0375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.1276 -5.4446 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
38.8358 -5.0338 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.8311 -4.2116 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.1220 -3.8083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.5363 -3.7988 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.2465 -4.2030 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
40.9517 -3.7901 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
41.6597 -4.1971 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.3628 -3.7877 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.3621 -2.9702 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
41.6520 -2.5637 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
40.9428 -2.9748 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.2325 -2.5707 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
41.6620 -5.0143 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
43.0715 -4.1947 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.7783 -3.7844 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.4827 -4.1930 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
45.1890 -3.7835 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
45.1875 -2.9654 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.4739 -2.5586 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.7706 -2.9705 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.5451 -5.4396 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
35.2967 -3.8137 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 5 1 0
9 11 1 0
11 12 2 0
12 13 1 0
13 14 1 0
13 18 1 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 1 0
18 19 2 0
14 20 2 0
15 21 1 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 22 1 0
8 28 1 0
1 29 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 403.47Molecular Weight (Monoisotopic): 403.1103AlogP: 3.34#Rotatable Bonds: 4Polar Surface Area: 96.16Molecular Species: NEUTRALHBA: 7HBD: 2#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 7.36CX Basic pKa: 1.40CX LogP: 4.96CX LogD: 4.69Aromatic Rings: 4Heavy Atoms: 29QED Weighted: 0.40Np Likeness Score: -1.34
References 1. Ghanim AM, Rezq S, Ibrahim TS, Romero DG, Kothayer H.. (2021) Novel 1,2,4-triazine-quinoline hybrids: The privileged scaffolds as potent multi-target inhibitors of LPS-induced inflammatory response via dual COX-2 and 15-LOX inhibition., 219 [PMID:33892270 ] [10.1016/j.ejmech.2021.113457 ]